abstract |
The invention relates to a method for the treatment of immunological diseases or pathological conditions which contain an immunological component, using certain Lck inhibitors which are already known as kinase inhibitors for therapy in oncology, optionally in combination with one or more others Drugs selected from NSAIDs, steroids, DMARDs, immunosuppressants, biological response modifiers and anti-infectives, pharmaceutical compositions comprising the Lck inhibitors together with the other drugs and the use of the Lck inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunological diseases or pathological conditions that contain an immunological component. |